Home  |  About us  |  Editorial board  |  Ahead of print  | Current issue  |  Archives  |  Submit article  |  Instructions |  Search  |   Subscribe  |  Advertise  |  Contacts  |  Login 
  Users Online: 635Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
This article has been cited by
1Fad or Trend? Rethinking the Sustainability of Connected Health
Sonia Chien-I Chen,Chenglian Liu,Ridong Hu
2Tackling Patient Centricity: A Report from the GRAPPA 2016 Annual Meeting
Niti Goel,Denis O’Sullivan,Ingrid Steinkoenig,Jana James,Chris A. Lindsay,Laura C. Coates,John Latella,Alexis Ogdie,Jeffrey Chau,Heidi Bertheussen,Willemina Campbell
The Journal of Rheumatology.2017;44(5)703
3Optimizing Clinical Research Participant Selection with Informatics
Chunhua Weng
Trends in Pharmacological Sciences.2015;36(11)706
4Site engagement for multi-site clinical trials
Dana Goodlett,Anna Hung,Ashley Feriozzi,Hien Lu,Justin E. Bekelman,C. Daniel Mullins
Contemporary Clinical Trials Communications.2020;19(11)100608
5Digital health revolution: perfect storm or perfect opportunity for pharmaceutical R&D?
Nick Hird,Samik Ghosh,Hiroaki Kitano
Drug Discovery Today.2016;21(6)900
6Community-based follow-up of participants of a mother-friendly clinical trial: A patient-centric methodology for pregnant women
Manish Gehani,Vara Prasad Pittala,Sree Kala Korvi,Suman Kapur
Health Care for Women International.2021;21(6)1
7Community-based follow-up of participants of a mother-friendly clinical trial: A patient-centric methodology for pregnant women
Xiong Liu,Luca A. Finelli,Greg L. Hersch,Iya Khalil
Health Care for Women International.2020;21(6)3761
8Patient-centered assessments: how can they be used in dental clinical trials?
Matheus França PERAZZO,Júnia Maria SERRA-NEGRA,Ramon Targino FIRMINO,Isabela Almeida PORDEUS,Paulo Antônio MARTINS-JÚNIOR,Saul Martins PAIVA
Brazilian Oral Research.2020;34(suppl 2)3761
9Patient centricity: lip service or genuine commitment? A qualitative examination of the pharmaceutical industry
Lea Prevel Katsanis,Dennis Pitta,Anne Morinville
International Journal of Pharmaceutical and Healthcare Marketing.2021;15(1)106
10Streamlining and cycle time reduction of the startup phase of clinical trials
Amani Abu-Shaheen,Ahmad Al Badr,Isamme Al Fayyad,Adel Al Qutub,Eissa Ali Faqeih,Mohamad Al-Tannir
11Paediatric Drug Development and Formulation Design—a European Perspective
Diana A. Van Riet-Nales,Piotr Kozarewicz,Brian Aylward,Rutger de Vries,Toine C. G. Egberts,Carin M. A. Rademaker,Alfred F. A. M. Schobben
AAPS PharmSciTech.2017;18(2)241
12Adherence to Web-Based Self-Assessments in Long-Term Direct-to-Patient Research: Two-Year Study of Multiple Sclerosis Patients
Peter Joseph Jongen,Ingrid E.H Kremer,Elena Hristodorova,Silvia M.A.A Evers,Anton Kool,Esther M van Noort,Mickaël Hiligsmann
Journal of Medical Internet Research.2017;19(7)e249
13Regulatory incentives to ensure better medicines for older people: From ICH E7 to the EMA reflection paper on quality aspects
Diana A. van Riet-Nales,Nasir Hussain,Katarina A.E. Sundberg,Doris Eggenschwyler,Cristina Ferris,Jean-Louis Robert,Francesca Cerreta
International Journal of Pharmaceutics.2016;512(2)343
14A descriptive follow-up interview study assessing patient-centred outcomes: Salford Lung Study in Asthma (SLS Asthma)
Lynda Doward,Henrik Svedsater,Diane Whalley,Rebecca Crawford,David Leather,James Lay-Flurrie,Nick Bosanquet
npj Primary Care Respiratory Medicine.2019;29(1)343
15Perspectives on Virtual (Remote) Clinical Trials as the “New Normal” to Accelerate Drug Development
Demissie Alemayehu,Robert Hemmings,Kannan Natarajan,Satrajit Roychoudhury
Clinical Pharmacology & Therapeutics.2021;29(1)343
16Perspectives on Virtual (Remote) Clinical Trials as the “New Normal” to Accelerate Drug Development
Thierry Oscar Edoh
Clinical Pharmacology & Therapeutics.2019;29(1)1
17Operationalizing Virtual Trials in Oncology—From Aspiration to Action
Kushal T. Kadakia,Daniel M. Halperin,Anaeze C. Offodile
JCO Clinical Cancer Informatics.2021;29(5)953
18Early-warning signals for disease activity in patients diagnosed with multiple sclerosis based on keystroke dynamics
J. Twose,G. Licitra,H. McConchie,K. H. Lam,J. Killestein
Chaos: An Interdisciplinary Journal of Nonlinear Science.2020;30(11)113133
19When innovation outpaces regulations: The legal challenges for direct-to-patient supply of investigational medicinal products
Maeve Malone,Pamela Ferguson,Amy Rogers,Isla S. Mackenzie,David A. Rorie,Thomas M. MacDonald
British Journal of Clinical Pharmacology.2021;30(11)113133
20A public and patient consultation process as an aid to design a person-centred randomized clinical trial
Jacqueline Rix,Sharon Docherty,Alexander C. Breen,Philip Sewell,Jonathan Branney
Health Expectations.2021;24(5)1639
21Predicting User Posting Activities in Online Health Communities with Deep Learning
Xiangyu Wang,Kang Zhao,Xun Zhou,Nick Street
ACM Transactions on Management Information Systems.2020;11(3)1
22Improving the Patient-Clinician Interface of Clinical Trials through Health Informatics Technologies
Jake Carrion
Journal of Medical Systems.2018;42(7)1
23Future Perspectives for Patient-Centric Pharmaceutical Drug Product Design with Regard to Solid Oral Dosage Forms
Nélio Drumond
Journal of Pharmaceutical Innovation.2020;15(3)318
24Original Abstracts from the 2018 European Meeting of ISMPP
Nélio Drumond
Current Medical Research and Opinion.2018;34(sup1)29
25Mitochondrial disease patient motivations and barriers to participate in clinical trials
Zarazuela Zolkipli-Cunningham,Rui Xiao,Amy Stoddart,Elizabeth M. McCormick,Amy Holberts,Natalie Burrill,Shana McCormack,Lauren Williams,Xiaoyan Wang,John L. P. Thompson,Marni J. Falk,Hemachandra Reddy
PLOS ONE.2018;13(5)e0197513

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal